Development of inhibitors of the major coronaviral protease as new antiviral agents against SARS (severe acute respiratory syndrome) and other coronavirus infections.

Hilgenfeld, Rolf (Principal Investigator (PI))

Institute of Biochemistry

Project: DFG Projects › DFG Individual Projects

Description

Status	finished
Effective start/end date	01.01.04 → 31.12.08

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

Research Areas and Centers

Academic Focus: Center for Infection and Inflammation Research (ZIEL)

DFG Research Classification Scheme

2.22-08 Pharmacy
2.21-04 Virology

Research on Coronavirus/Covid-19

Research on SARS-CoV-2 / COVID-19

Project Details

gepris.dfg.de

Development of inhibitors of the major coronaviral protease as new antiviral agents against SARS (severe acute respiratory syndrome) and other coronavirus infections.

Project Details

Description

UN Sustainable Development Goals

Research Areas and Centers

DFG Research Classification Scheme

Research on Coronavirus/Covid-19

Project Details

Fingerprint